Viatris (VTRS) Receivables (2019 - 2026)
Viatris (VTRS) posted quarterly Receivables of $3.6 billion for Q1 2026, down 2.49% year-over-year from $3.7 billion in Q1 2025, and up 2.59% quarter-over-quarter from $3.5 billion in Q4 2025.
Viatris (VTRS) Receivables (2019 - 2026) Analysis & Trends
Viatris' Receivables history runs 8 years deep, the most recent figure standing at $3.6 billion for Q1 2026.
- In Q1 2026, Receivables fell 2.49% year-over-year to $3.6 billion; the TTM figure through Mar 2026 stood at $3.6 billion (down 2.49% YoY), while the FY2025 annual figure was $3.5 billion, down 7.49% from the prior year.
- Receivables for Q1 2026 stood at $3.6 billion, up from $3.5 billion in the prior quarter.
- The five-year high for Receivables was $4.6 billion in Q1 2022, with the low at $3.5 billion in Q4 2025.
- The 5-year median for Receivables is $4.1 billion (2023), against an average of $4.1 billion.
- The sharpest annual moves came in 2022 and 2024: Receivables dropped 20.86% in 2022, then climbed 12.61% in 2024.
- Viatris' Receivables stood at $4.4 billion in 2022, then rose by 4.37% to $4.6 billion in 2023, then dropped by 17.69% to $3.8 billion in 2024, then dropped by 7.49% to $3.5 billion in 2025, then increased by 2.59% to $3.6 billion in 2026.
- Business Quant data shows VTRS's Receivables at $3.6 billion in Q1 2026, $3.5 billion in Q4 2025, and $3.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 456.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.67 Bn |
| Mar 31, 2026 | 3.58 Bn |
| Dec 31, 2025 | 3.49 Bn |
| Sep 30, 2025 | 3.83 Bn |
| Jun 30, 2025 | 3.72 Bn |
| Mar 31, 2025 | 3.67 Bn |
| Dec 31, 2024 | 3.77 Bn |
| Sep 30, 2024 | 4.58 Bn |
| Jun 30, 2024 | 4.45 Bn |
| Mar 31, 2024 | 4.47 Bn |
| Dec 31, 2023 | 4.58 Bn |
| Sep 30, 2023 | 4.25 Bn |
| Jun 30, 2023 | 4.09 Bn |
| Mar 31, 2023 | 3.97 Bn |
| Dec 31, 2022 | 4.39 Bn |
| Sep 30, 2022 | 3.84 Bn |
| Jun 30, 2022 | 4.29 Bn |
| Mar 31, 2022 | 4.63 Bn |
| Dec 31, 2021 | 4.76 Bn |
| Sep 30, 2021 | 4.85 Bn |